Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2018-11-28 Declaration of Voting R…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Results of 2018 AGM 2 pages 394.7KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal communication to the ASX Limited regarding the results of resolutions passed at the Mayne Pharma Group Limited 2018 Annual General Meeting held on 29 November 2018. It includes detailed voting results for each resolution, including re-elections of directors and adoption of remuneration reports. The document references compliance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, which pertain to disclosure of voting results. The content is focused on the official announcement of voting outcomes rather than the meeting materials or the full annual report. The document length is relatively short (3037 characters) and it primarily reports the voting results, fitting the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-11-28 English
Final Director's Interest Notice 2 pages 727.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including the number and class of securities held, and notes the date the director ceased to be a director. This is a report of personal share transactions or holdings by a company director. The document length is short and focused solely on director share interests, matching the definition of Director's Dealing filings. Therefore, the appropriate classification is DIRS (Director's Dealing).
2018-11-28 English
Appendix 3B 9 pages 685.4KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B' and is an announcement related to the issue of new securities, specifically the issuance of 500,000 fully paid ordinary shares and employee options under an Employee Share Option Plan. It includes detailed information about the securities issued, their terms, issue price, purpose (long-term incentive), and compliance with ASX listing rules. The document is a formal notification to the Australian Securities Exchange (ASX) regarding the new share issue and application for quotation of additional securities. It does not contain financial statements, management discussion, or audit information. It is not a report but an announcement of a capital raising event and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length (12,835 characters) and detailed content support this classification with high confidence.
2018-10-30 English
Notice of Annual General Meeting / Proxy Form 12 pages 2.8MB
AGM Information Classification · 95% confidence The document is titled 'Notice of Annual General Meeting' and includes detailed information about the date, time, and location of the AGM, resolutions to be voted on, election and re-election of directors, remuneration reports, proxy voting instructions, and explanatory notes related to the AGM agenda. It does not contain the actual financial statements or reports but references them as items to be considered at the meeting. The document is a formal notice sent to shareholders to inform them about the AGM and the business to be conducted, including voting procedures. This matches the definition of 'AGM Information' (AGM-R), which covers presentations and materials shared during the Annual General Meeting. The document is lengthy (15,000 characters) and contains detailed meeting information, not just a brief announcement or proxy statement. Therefore, the correct classification is AGM-R with high confidence.
2018-10-28 English
Retirement of Director 1 page 249.3KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 29 October 2018 regarding a non-executive director, Mr. Phil Hodges, not standing for re-election at the upcoming Annual General Meeting. It discusses the director's retirement and contributions but does not contain financial data, audit information, or detailed management reports. It is an announcement about a change in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this management change, confirming the classification.
2018-10-28 English
MYX announces acquisition of FDA approved halobetasol foam 3 pages 429.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 26 October 2018 about Mayne Pharma's acquisition of FDA-approved halobetasol foam. It details the acquisition terms, strategic rationale, leadership changes, and product information. The content focuses on a corporate acquisition and business update rather than financial results, regulatory filings, or detailed financial statements. There is no indication of this being a full annual or interim report, audit report, earnings release, or other financial report. The document is a corporate announcement about a capital transaction and business update, fitting the Capital/Financing Update category (CAP). The document length (8834 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2018-10-25 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.